Alzheimer's Disease Research
Alzheimer's disease (AD), the most common type of dementia, is an irreversible and progressive neurodegenerative disorder causing cognitive and functional impairment. It is characterized by formation of protein aggregates and progressive loss of neurons in the central nervous system (CNS). The symptoms of AD include short-term memory loss, confusion, irritability, aggression and mood swings, progressing to long-term memory deficit, withdrawal from social interactions and subsequently a loss in higher central functioning.
Alzheimer's Disease Research Products Targets
- Others (23)
- Cyclooxygenase (24)
- Complement (2)
- AMPA Receptor (45)
- Nicotinic (α7) Receptor (25)
- Nicotinic (α4β2) Receptor (14)
- NMDA Receptor (87)
- Kainate Receptor (22)
- Microtubule (19)
- DYRK (3)
- Cholinesterase (10)
- Autophagy (44)
- Antioxidant (19)
- Amyloid beta Peptide (28)
- Estrogen and Related Receptor (33)
- Glycogen Synthase Kinase 3 (20)
- gamma-Secretase (9)
Products for Alzheimer's Disease Research - Page 24
- Cat.No. Product Name Information/Activity
-
BCC7869
LY 2087101
913186-74-0
-
BCC7468
Sazetidine A dihydrochloride
1197329-42-2
-
BCC7920
A 582941
848591-90-2
-
BCC6200
A 844606
861119-08-6
-
BCC7827
AR-R 17779 hydrochloride
178419-42-6
-
BCC7948
GTS 21 dihydrochloride
GTS-21 dihydrochloride is a selective α7 nicotinic acetylcholine receptor agonist, has recently been established as a promising treatment for inflammation.
-
BCC5972
PHA 543613 hydrochloride
478149-53-0
-
BCC7574
PHA 568487
527680-57-5
-
BCC7700
S 24795
304679-75-2
-
BCC6182
SEN 12333
874450-44-9


